Medicenna Therapeutics Analyst Ratings
Medicenna Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Medicenna Therapeutics (MDNA) rating was a maintained with a price target of $8.00 to $3.00. The current price Medicenna Therapeutics (MDNA) is trading at is $0.38, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/14/2023 | 698.51% | Oppenheimer | $8 → $3 | Maintains | Outperform |
| 08/10/2023 | 565.42% | HC Wainwright & Co. | → $2.5 | Reiterates | Buy → Buy |
| 07/31/2023 | 565.42% | HC Wainwright & Co. | → $2.5 | Reiterates | Buy → Buy |
| 06/28/2023 | 565.42% | HC Wainwright & Co. | → $2.5 | Reiterates | Buy → Buy |
| 02/08/2023 | 565.42% | HC Wainwright & Co. | → $2.5 | Reiterates | → Buy |
| 11/08/2022 | 565.42% | HC Wainwright & Co. | $4 → $2.5 | Maintains | Buy |
| 08/16/2022 | 964.68% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 06/23/2022 | 2561.7% | Oppenheimer | $12 → $10 | Maintains | Outperform |
| 06/23/2022 | 1230.85% | HC Wainwright & Co. | $7 → $5 | Maintains | Buy |
| 06/01/2021 | 1763.19% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 12/18/2020 | 3094.04% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 12/17/2020 | 3094.04% | Oppenheimer | → $12 | Initiates Coverage On | → Outperform |
| 09/10/2020 | 2029.36% | HC Wainwright & Co. | → $8 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 2023年08月14日 | 698.51% | 奧本海默 | $8→$3 | 維護 | 跑贏大盤 |
| 2023年08月10日 | 565.42% | HC Wainwright公司 | →$2.5 | 重申 | 購買→購買 |
| 07/31/2023 | 565.42% | HC Wainwright公司 | →$2.5 | 重申 | 購買→購買 |
| 2023年6月28日 | 565.42% | HC Wainwright公司 | →$2.5 | 重申 | 購買→購買 |
| 02/08/2023 | 565.42% | HC Wainwright公司 | →$2.5 | 重申 | →購買 |
| 11/08/2022 | 565.42% | HC Wainwright公司 | $4→$2.5 | 維護 | 買 |
| 08/16/2022 | 964.68% | HC Wainwright公司 | $5→$4 | 維護 | 買 |
| 2022/06/23 | 2561.7% | 奧本海默 | $12→$10 | 維護 | 跑贏大盤 |
| 2022/06/23 | 1230.85% | HC Wainwright公司 | $7→$5 | 維護 | 買 |
| 06/01/2021 | 1763.19% | HC Wainwright公司 | $8→$7 | 維護 | 買 |
| 12/18/2020 | 3094.04% | 奧本海默 | →$12 | 開始承保 | →跑贏大盤 |
| 12/17/2020 | 3094.04% | 奧本海默 | →$12 | 開始承保 | →跑贏大盤 |
| 09/10/2020 | 2029.36% | HC Wainwright公司 | →$8 | 開始承保 | →購買 |
What is the target price for Medicenna Therapeutics (MDNA)?
Medicenna Treeutics(MDNA)的目標價格是多少？
The latest price target for Medicenna Therapeutics (NASDAQ: MDNA) was reported by Oppenheimer on August 14, 2023. The analyst firm set a price target for $3.00 expecting MDNA to rise to within 12 months (a possible 698.51% upside). 7 analyst firms have reported ratings in the last year.
奧本海默於2023年8月14日報道了Medicenna治療公司(納斯達克：mDNA)的最新目標價。這家分析公司將目標價定為3美元，預計mDNA將在12個月內上漲至(可能上漲698.51%)。去年有7家分析公司公佈了評級。
What is the most recent analyst rating for Medicenna Therapeutics (MDNA)?
Medicenna治療公司(MDNA)的最新分析師評級是多少？
The latest analyst rating for Medicenna Therapeutics (NASDAQ: MDNA) was provided by Oppenheimer, and Medicenna Therapeutics maintained their outperform rating.
奧本海默公司提供了對美第奇拿治療公司(納斯達克代碼：mDNA)的最新分析師評級，美第奇拿治療公司維持了其表現優於大盤的評級。
When is the next analyst rating going to be posted or updated for Medicenna Therapeutics (MDNA)?
Medicenna治療公司(MDNA)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Medicenna Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Medicenna Therapeutics was filed on August 14, 2023 so you should expect the next rating to be made available sometime around August 14, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Medicenna Treeutics的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。Medicenna治療公司的上一次評級是在2023年8月14日提交的，所以你應該預計下一次評級將在2024年8月14日左右提供。
Is the Analyst Rating Medicenna Therapeutics (MDNA) correct?
分析師對Medicenna Treeutics(MDNA)的評級正確嗎？
While ratings are subjective and will change, the latest Medicenna Therapeutics (MDNA) rating was a maintained with a price target of $8.00 to $3.00. The current price Medicenna Therapeutics (MDNA) is trading at is $0.38, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的Medicenna Treeutics(MDNA)評級保持不變，目標價在8.00美元至3.00美元之間。Medicenna Treateutics(MDNA)目前的交易價格為0.38美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。
